EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Kawasaki disease complicated by macrophage activation syndrome treated with canakinumab

Stejara A Netea iD, Diana van Stijn iD, Mariken P Gruppen iD, J Merlijn van den Berg iD, Nico A Blom iD, Irene M Kuipers iD, Taco W Kuijpers iD

Journal of Human Immunity · 06.07.2026 · 2 (4)

DOI: 10.70962/jhi.20250240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Human Immunity, online erschienen am 09.04.2026. Verfasst von Stejara A Netea und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, University o…. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SK Foundation, Dutch Foundation Fonds Kind … Handicap.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An infant presented with macrophage activation syndrome as part of Kawasaki disease, and was first treated with canakinumab, followed by methylprednisolone and IVIG. Despite early treatment, giant coronary artery aneurysms developed transiently, questioning the singular role of IL-1 in KD.

Autor:innen und Institutionen

  • Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Pediatric Cardiology, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Blood Cell Research, Sanquin Research Institute, University of Amsterdam, Amsterdam, The Netherlands.

ORCID-Profile: Stejara A Netea, Diana van Stijn, Mariken P Gruppen, J Merlijn van den Berg, Nico A Blom, Irene M Kuipers, Taco W Kuijpers

Förderung

  • SK Foundation
  • Dutch Foundation Fonds Kind … Handicap

Zitieren

APA

Netea, S. A., van Stijn, D., Gruppen, M. P., van den Berg, J. M., Blom, N. A., Kuipers, I. M., & Kuijpers, T. W. (2026). Kawasaki disease complicated by macrophage activation syndrome treated with canakinumab. Journal of Human Immunity, 2(4). https://doi.org/10.70962/jhi.20250240

Vancouver

Netea SA, van Stijn D, Gruppen MP, van den Berg JM, Blom NA, Kuipers IM, et al. Kawasaki disease complicated by macrophage activation syndrome treated with canakinumab. Journal of Human Immunity. 2026;2(4). doi:10.70962/jhi.20250240

BibTeX
@article{Netea2026,
  author = {Netea, Stejara A and van Stijn, Diana and Gruppen, Mariken P and van den Berg, J Merlijn and Blom, Nico A and Kuipers, Irene M and Kuijpers, Taco W},
  title = {Kawasaki disease complicated by macrophage activation syndrome treated with canakinumab},
  journal = {Journal of Human Immunity},
  year = {2026},
  volume = {2},
  number = {4},
  doi = {10.70962/jhi.20250240}
}
Kostenlos starten →